Solara Active Pharma Sciences Limited

NSEI:SOLARA Rapporto sulle azioni

Cap. di mercato: ₹36.6b

Solara Active Pharma Sciences Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Poorvank Purohit

Amministratore delegato

₹39.8m

Compenso totale

Percentuale dello stipendio del CEO72.9%
Mandato del CEO1.8yrs
Proprietà del CEOn/a
Durata media del management1.8yrs
Durata media del Consiglio di amministrazione1.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

The Market Lifts Solara Active Pharma Sciences Limited (NSE:SOLARA) Shares 26% But It Can Do More

Sep 13
The Market Lifts Solara Active Pharma Sciences Limited (NSE:SOLARA) Shares 26% But It Can Do More

Further Upside For Solara Active Pharma Sciences Limited (NSE:SOLARA) Shares Could Introduce Price Risks After 30% Bounce

Jul 20
Further Upside For Solara Active Pharma Sciences Limited (NSE:SOLARA) Shares Could Introduce Price Risks After 30% Bounce

Slammed 32% Solara Active Pharma Sciences Limited (NSE:SOLARA) Screens Well Here But There Might Be A Catch

Jun 05
Slammed 32% Solara Active Pharma Sciences Limited (NSE:SOLARA) Screens Well Here But There Might Be A Catch

A Look At The Fair Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

May 11
A Look At The Fair Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

Investors Still Aren't Entirely Convinced By Solara Active Pharma Sciences Limited's (NSE:SOLARA) Revenues Despite 28% Price Jump

Apr 19
Investors Still Aren't Entirely Convinced By Solara Active Pharma Sciences Limited's (NSE:SOLARA) Revenues Despite 28% Price Jump

Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?

Mar 13
Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?

Even With A 26% Surge, Cautious Investors Are Not Rewarding Solara Active Pharma Sciences Limited's (NSE:SOLARA) Performance Completely

Feb 23
Even With A 26% Surge, Cautious Investors Are Not Rewarding Solara Active Pharma Sciences Limited's (NSE:SOLARA) Performance Completely

Further Upside For Solara Active Pharma Sciences Limited (NSE:SOLARA) Shares Could Introduce Price Risks After 25% Bounce

Jan 04
Further Upside For Solara Active Pharma Sciences Limited (NSE:SOLARA) Shares Could Introduce Price Risks After 25% Bounce

Solara Active Pharma Sciences Limited's (NSE:SOLARA) Intrinsic Value Is Potentially 81% Above Its Share Price

May 12
Solara Active Pharma Sciences Limited's (NSE:SOLARA) Intrinsic Value Is Potentially 81% Above Its Share Price

Estimating The Intrinsic Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

Nov 08
Estimating The Intrinsic Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?

Sep 30
Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?

Are Investors Undervaluing Solara Active Pharma Sciences Limited (NSE:SOLARA) By 22%?

Aug 03
Are Investors Undervaluing Solara Active Pharma Sciences Limited (NSE:SOLARA) By 22%?

Solara Active Pharma Sciences (NSE:SOLARA) Is Making Moderate Use Of Debt

Jun 19
Solara Active Pharma Sciences (NSE:SOLARA) Is Making Moderate Use Of Debt

Newsflash: Solara Active Pharma Sciences Limited (NSE:SOLARA) Analysts Have Been Trimming Their Revenue Forecasts

Feb 17
Newsflash: Solara Active Pharma Sciences Limited (NSE:SOLARA) Analysts Have Been Trimming Their Revenue Forecasts

A Look At The Fair Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

Dec 21
A Look At The Fair Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Poorvank Purohit rispetto agli utili di Solara Active Pharma Sciences?
DataCompenso totaleStipendioGuadagni aziendali
Sep 30 2024n/an/a

-₹5b

Jun 30 2024n/an/a

-₹6b

Mar 31 2024₹40m₹29m

-₹6b

Dec 31 2023n/an/a

-₹3b

Sep 30 2023n/an/a

-₹325m

Jun 30 2023n/an/a

-₹253m

Mar 31 2023₹5mn/a

-₹222m

Compensazione vs Mercato: La retribuzione totale di Poorvank ($USD 471.43K ) è superiore alla media delle aziende di dimensioni simili nel mercato Indian ($USD 273.81K ).

Compensazione vs guadagni: La retribuzione di Poorvank è aumentata nonostante l'azienda non sia redditizia.


AMMINISTRATORE DELEGATO

Poorvank Purohit (45 yo)

1.8yrs

Mandato

₹39,800,000

Compensazione

Mr. Poorvank Purohit serves as Chief Executive Officer of Solara Active Pharma Sciences Limited since February 03, 2023 and serves as its Director & Managing Director since July 2023. He started his career...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Poorvank Purohit
MD, CEO & Director1.8yrs₹39.80mNessun dato
Arun Baskaran
Chief Financial Officerless than a year₹700.00kNessun dato
Mohan Muthunarayanan
COO & Executive Director2.3yrs₹3.80mNessun dato
Suddapalli Krishna
Company Secretary6.7yrs₹4.80mNessun dato
Arun Pillai
Founder & Non-Executive Directorno dataNessun dato5.71%
₹ 2.1b
Hero Velladurai
Chief Scientific Officerless than a yearNessun datoNessun dato
V. Moorthy
Chief Quality Officerno dataNessun datoNessun dato

1.8yrs

Durata media

Gestione esperta: Il team dirigenziale di SOLARA non è considerato esperto (durata media 1.8 anni), il che suggerisce un nuovo team.


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Poorvank Purohit
MD, CEO & Director1.3yrs₹39.80mNessun dato
Mohan Muthunarayanan
COO & Executive Directorless than a year₹3.80mNessun dato
Arun Pillai
Founder & Non-Executive Director3.3yrsNessun dato5.71%
₹ 2.1b
Manish Gupta
Non-Executive Directorless than a yearNessun datoNessun dato
Kausalya Santhanam
Independent Director6.6yrs₹1.50mNessun dato
Ramakrishnan Rajagopal
Independent Chairman6.6yrs₹1.50m0.010%
₹ 3.8m
Rajendra Srivastava
Independent Directorless than a year₹200.00kNessun dato
Kartheek Raju
Non-Executive Non-Independent Director3.3yrsNessun datoNessun dato
Rajiv Nabar
Independent Directorless than a year₹400.00kNessun dato

1.3yrs

Durata media

57yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di SOLARA non è considerato esperto (durata media del mandato 1.3 anni), il che suggerisce un nuovo consiglio.